Neurocrine Biosciences, Inc. (FRA:NB3)

Neurocrine Biosciences Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	10,958	12,044	13,349	11,712	10,744	7,105
Market Cap Growth	-25.43%	-9.78%	13.98%	9.01%	51.23%	-2.96%
Enterprise Value	10,101	11,503	12,439	10,969	10,261	6,829
Last Close Price	109.85	120.75	132.80	118.85	111.94	73.88
PE Ratio	26.88	29.55	40.49	51.85	74.32	90.18
PS Ratio	4.50	4.94	5.87	6.86	7.71	7.13
PB Ratio	3.95	4.35	5.34	5.80	6.72	5.88
P/TBV Ratio	3.95	4.35	5.34	5.91	6.90	5.88
P/FCF Ratio	17.18	18.89	24.80	35.80	35.56	34.66
P/OCF Ratio	16.44	18.07	23.21	33.20	33.83	31.50
EV/Sales Ratio	4.16	4.72	5.47	6.43	7.37	6.85
EV/EBITDA Ratio	16.35	20.26	20.64	29.14	41.44	35.51
EV/EBIT Ratio	18.70	21.22	21.57	30.71	44.04	37.38
EV/FCF Ratio	15.84	18.04	23.11	33.53	33.96	33.32
Debt / Equity Ratio	0.14	0.14	0.18	0.19	0.15	0.32
Debt / EBITDA Ratio	0.65	0.65	0.68	0.99	0.94	1.88
Debt / FCF Ratio	0.63	0.63	0.82	1.19	0.81	1.89
Net Debt / Equity Ratio	-0.31	-0.31	-0.24	-0.27	-0.42	-0.20
Net Debt / EBITDA Ratio	-1.51	-1.51	-0.99	-1.45	-2.74	-1.24
Net Debt / FCF Ratio	-1.35	-1.35	-1.11	-1.67	-2.25	-1.16
Asset Turnover	0.69	0.69	0.68	0.67	0.67	0.60
Inventory Turnover	16.90	16.90	15.99	16.48	14.85	11.71
Quick Ratio	2.92	2.92	3.06	2.25	2.49	3.65
Current Ratio	3.39	3.39	3.40	2.45	2.70	3.96
Return on Equity (ROE)	16.38%	16.38%	14.16%	12.68%	10.03%	7.17%
Return on Assets (ROA)	9.53%	9.53%	10.71%	8.78%	7.01%	6.82%
Return on Invested Capital (ROIC)	18.73%	20.50%	23.31%	22.75%	17.26%	19.95%
Return on Capital Employed (ROCE)	16.40%	16.40%	18.60%	15.20%	13.60%	11.40%
Earnings Yield	3.72%	3.38%	2.47%	1.93%	1.35%	1.11%
FCF Yield	5.82%	5.29%	4.03%	2.79%	2.81%	2.89%
Buyback Yield / Dilution	1.16%	1.16%	-2.67%	-2.12%	-1.02%	-0.10%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.